A Phase 4 interventional study of percutaneous coronary intervention in NSTEMI, sponsored by University of Jena. Completed at 1 site in Germany. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2010-07-12.
Sponsored by University of Jena · Phase 4, Interventional, and Treatment
It is assumed that patients with non-ST-elevation myocardial infarctions (NSTEMI) showing an infero- or posterolateral occluded culprit artery (OCA) during diagnostic angiography frequently elude standard 12-lead electrocardiogram diagnosis. In addition, coronary collaterals may have beneficial effects in patients with OCA.
We examined consecutive NSTEMI patients within 48 h of symptom onset. All patients underwent early invasive angiography plus optimal medical therapy. We compared baseline characteristics, procedural findings including analysis of TIMI-flow and collaterals using the Rentrop-classification, 30-day and 6-months major adverse cardiovascular events (MACE) in patients with and without totally OCA.
146 studies on the registry are indexed under Non-ST Elevated Myocardial Infarction; 40 are open to participants now.
This study's enrollment of 602 is above the median of 300 across 82 interventional studies indexed under Non-ST Elevated Myocardial Infarction.
Browse Non-ST Elevated Myocardial Infarction studies →University of Jena is the lead sponsor of 89 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
An occluded lesion was defined as a lesion with 100% stenosis or TIMI-flow grade 0 or 1.
Procedure: percutaneous coronary intervention
A non-occluded lesion was defined as a lesion without 100% stenosis or TIMI-flow grade 0 or 1.
Procedure: percutaneous coronary intervention
early timing
Also known as: early invasive treatment strategy in NSTEMI
MACE
composite of death, reinfarction and readmission for unstable angina within 6 months after inclusion
Time frame: 6 months
CK and CK-MB
Venous blood samples were taken at admission (baseline), and every 6 h subsequently for a period of 48 h.
Time frame: 48 hours
This study is completed, as verified in Jul 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Non-ST Elevated Myocardial Infarction→
University of Jena